aTyr Pharma, Inc. (ATYR) vs MDxHealth S.A. (MDXH)
A side-by-side comparison of aTyr Pharma, Inc. and MDxHealth S.A. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATYR
aTyr Pharma, Inc.
$0.29HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
MDXH
MDxHealth S.A.
$0.61HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
Total return — ATYR vs MDXH
growth of $100 · dividends reinvested · last 2yATYR -83.2% (-59.1%/yr)MDXH -78.1% (-53.2%/yr)MDXH compounded faster over this window
ATYR MDXH
ATYR vs MDXH: by the numbers
- •MDXH is the larger company ($31M vs $28M market cap).
- •Both run net losses; MDXH's is the smaller (-31.07% vs -32003.68% net margin).
- •MDXH grew revenue faster over the past five years (42.35% vs -38.74% CAGR).
Metrics side by side
Valuation
| Metric | ATYR | MDXH |
|---|---|---|
| P/S ratio | 149.35 | N/A |
| P/B ratio | 0.58 | N/A |
Profitability
| Metric | ATYR | MDXH |
|---|---|---|
| Gross margin | -717.37% | 59.74% |
| Operating margin | -40856.32% | -14.28% |
| Net margin | -32003.68% | -31.07% |
| ROE | -124.64% | N/A |
| ROIC | -109.29% | -15.35% |
Growth (annualized)
| Metric | ATYR | MDXH |
|---|---|---|
| Revenue CAGR (5Y) | -38.74% | 42.35% |
Frequently asked
- Which has grown faster, ATYR or MDXH?
- Over the past five years, MDXH grew revenue faster — ATYR at a -38.74% CAGR versus MDXH at 42.35%.
Go deeper
Dig into the metrics
aTyr Pharma ROEMDxHealth ROEaTyr Pharma operating marginMDxHealth operating marginaTyr Pharma revenue growthMDxHealth revenue growthaTyr Pharma free cash flowMDxHealth free cash flow
aTyr Pharma & MDxHealth appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.